AstraZeneca COVID vaccine linked with small risk of low blood platelets: Study

The Oxford-AstraZeneca vaccine, known in India as Covishield, may be associated with a very small risk of developing a blood condition characterised by low platelet counts, according to a nationwide study in the UK. The increased risk of the condition, known as idiopathic thrombocytopenic purpura (ITP), is estimated to be 11 per million doses, similar to figures seen in vaccines for flu, and measles, mumps, and rubella (MMR), the researchers said.

from IndiaTV India: Google News Feed https://ift.tt/2Thr3Ms
https://ift.tt/3v9KUKQ